Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis

Int Arch Allergy Immunol. 2006;139(3):265-70. doi: 10.1159/000091172. Epub 2006 Jan 30.

Abstract

Background: Mastocytosis is associated with a pathological increase in tissue mast cells. Associated skeletal problems include a decrease in bone density and pathological fractures.

Methods: In order to explore the relationship between bone density and the severity of mastocytosis, 21 patients with mastocytosis who underwent dual-energy X-ray absorptiometry were entered into this study. Correlation coefficients were computed between Z-scores and demographic, clinical and laboratory data. Femoral neck Z-scores correlated with serum tryptase levels when all the patients were considered (p=0.029).

Results and conclusion: Patients with less severe disease had significantly lower values at the L1-L4 spine (p=0.046) and femoral neck (p=0.029) Z-scores compared to patients with more severe disease. Most patients who had low Z-scores (between -1 and -2.5) were under 50 years of age, had less severe disease and had lower serum tryptase levels. A history of gastroesophageal reflux disease and a history of hypotensive episodes correlated with lower L1-L4 spine Z-scores (p<0.05). Thus, patients with less severe disease and lower serum tryptase levels should in particular have their bone density determined with treatment appropriate to the findings.

MeSH terms

  • Absorptiometry, Photon
  • Bone Density / physiology*
  • Cohort Studies
  • Female
  • Femur Neck / pathology
  • Humans
  • Lumbar Vertebrae / pathology
  • Male
  • Mastocytosis / enzymology
  • Mastocytosis / pathology*
  • Middle Aged
  • Radius / pathology
  • Serine Endopeptidases / blood*
  • Statistics, Nonparametric
  • Tryptases

Substances

  • Serine Endopeptidases
  • Tryptases